arbekacin has been researched along with Infant, Premature, Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, W; Ishii, S; Matsunaga, M; Sato, T; Shi, D; Takano, T; Tanaka, K; Yabe, S; Yamamoto, T; Yamazaki, H | 1 |
| Kinoshita, D | 1 |
| Nitta, Y; Sunakawa, K; Yokota, T | 1 |
3 other study(ies) available for arbekacin and Infant, Premature, Diseases
| Article | Year |
|---|---|
Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Dibekacin; Humans; Immunoglobulin G; Immunologic Factors; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Staphylococcal Scalded Skin Syndrome | 2011 |
[Evaluation of once a day of arbekacin administration to neonates as a new object of peak concentration].
Topics: Anti-Infective Agents; Dibekacin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2010 |
[MRSA infections in neonates and premature infants].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |